Epilepsy Foundation: New Therapy Commercialisation Grant Programme – Letters of Intent

This supports the development of new therapies for epilepsy, including medicines, biologics or devices. The programme also encourages one-to-one matching grants to academic and commercial entities to support the commercialisation of novel approaches to the treatment of epilepsy. Areas of interest include:

  • novel approaches to treatment;
  • platform technology to advance screening techniques that can be utilised by multiple laboratories, including utility of techniques for early proof-of-concept trials;
  • adaptation of treatment in development for another therapeutic area to assess utility for epilepsy.

Please note: Applicants are strongly encouraged to discuss their proposals with Adelaide Enterprise in terms of potential commercial partners or commercialisation path.

Funding & Duration

Grants are worth up to USD $350,000 (approx AUD $484,000) for one to two years.


Investigators worldwide may apply. Preference is given to proposals that:

  • already have a commercial partner engaged to assist with development,
  • that have committed matching funding from a third party source,
  • that might not otherwise be funded through traditional sources, and
  • that encourage collaboration between scientists and industry.

Submission Requirements & Due Date

Further Information

Need Help?

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Proof of Concept, Market Testing, Commercialisation. Bookmark the permalink.

Comments are closed.